Who owns the REVERE trademark?

The REVERE trademark is owned by Revere Pharmaceuticals, Inc..

What class is the REVERE trademark registered in?

The REVERE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for REVERE?

The USPTO serial number for REVERE is 97861964.

What is the registration number for REVERE?

REVERE is registered under USPTO registration number 0.

Sealvo

Home Search: REVEREREVERE #97861964

Back

Updated Sep 19, 2026·41 searches this week

View on USPTO TSDR Find similar marks

REV

USPTO Trademark Record

PENDING

REVERE

SN 97861964·Reg 0·Filed Mar 28, 2023

Owner Revere Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

REVERE (Serial No. 97861964), Registration No. 0, is a pending US trademark filed on Mar 28, 2023 by Revere Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Conflict Analysis

Full conflict analysis for REVERE (SN 97861964) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

REVERE (Reg. #0) is a pending US trademark that was filed in 2023 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 28, 2023

SERIAL

97861964

REG#

REGISTERED

Dec 31, 1969

Filing Information

StatusPENDING

Filing DateMar 28, 2023

Serial Number97861964

Registration No.0

Registration DateDec 31, 1969

Status DateMar 12, 2026

Published for OppositionJan 14, 2025

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

24 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 13, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Mar 12, 2026

SOU EXTENSION 2 GRANTED

SOU TEAS EXTENSION RECEIVED

Mar 11, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Mar 11, 2026

SOU EXTENSION 2 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 12, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 11, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Sep 11, 2025

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Sep 11, 2025

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 11, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 14, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 14, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 08, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 19, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 13, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 13, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 13, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

SUSPENSION LETTER WRITTEN

Mar 13, 2024

SUSPENSION LETTER WRITTEN

CORRESPONDENCE E-MAILED

Mar 13, 2024

CORRESPONDENCE E-MAILED

NON-FINAL ACTION WRITTEN

Dec 23, 2023

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 23, 2023

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 23, 2023

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 21, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 20, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 31, 2023

NEW APPLICATION ENTERED

Other Marks by Revere Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

LOG

LogoMark

97861962

Revere Pharmaceuticals, Inc.

ABANDONED

REV

REVERE PHARMACEUTICALS

97861966

Revere Pharmaceuticals, Inc.

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

REV

REVERE

87268617

Barwis Enterprises, Inc.

ABANDONED

REV

REVERE

90054035

ADAMA Agan Ltd.

ABANDONED

REV

REVERE

97315709

Revere Diagnostics, LLC

ABANDONED

REV

REVERE

85753996

ADAMA AGAN LTD.

ABANDONED

Other Marks by John V. Hobgood, Esquire

Additional USPTO filings handled by the same attorney of record.

MIP

88890265

REGISTERED

SMA

SMARTFOCUS

98909474

REGISTERED

QUA

QUAD-ELEVATION

99029979

REGISTERED

GUA

GUARDIAN 400

77888640

REGISTERED

REVERE

Run a conflict check

Other Marks by Revere Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by John V. Hobgood, Esquire

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company